CompuGroup Net Income from 2010 to 2026

0MSD Stock   16.22  0.00  0.00%   
CompuGroup Medical Net Income yearly trend continues to be comparatively stable with very little volatility. Net Income will likely drop to about 39.1 M in 2026. From the period from 2010 to 2026, CompuGroup Medical Net Income quarterly data regression had r-value of  0.49 and coefficient of variation of  54.13. View All Fundamentals
 
Net Income  
First Reported
2009-03-31
Previous Quarter
-6.5 M
Current Value
10.9 M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check CompuGroup Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CompuGroup Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 134.8 M, Interest Expense of 40.3 M or Total Revenue of 1.4 B, as well as many indicators such as . CompuGroup financial statements analysis is a perfect complement when working with CompuGroup Medical Valuation or Volatility modules.
  
This module can also supplement various CompuGroup Medical Technical models . Check out the analysis of CompuGroup Medical Correlation against competitors.
The evolution of Net Income for CompuGroup Medical AG provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how CompuGroup Medical compares to historical norms and industry peers.

Latest CompuGroup Medical's Net Income Growth Pattern

Below is the plot of the Net Income of CompuGroup Medical AG over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in CompuGroup Medical financial statement analysis. It represents the amount of money remaining after all of CompuGroup Medical AG operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is CompuGroup Medical's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CompuGroup Medical's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 34.76 M10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

CompuGroup Net Income Regression Statistics

Arithmetic Mean44,145,826
Geometric Mean37,386,206
Coefficient Of Variation54.13
Mean Deviation18,694,379
Median39,057,039
Standard Deviation23,898,227
Sample Variance571.1T
Range86.4M
R-Value0.49
Mean Square Error460.3T
R-Squared0.24
Significance0.04
Slope2,340,040
Total Sum of Squares9138T

CompuGroup Net Income History

202639.1 M
202539.8 M
202434.6 M
202345.9 M
202273.4 M
202169 M
202073.2 M

About CompuGroup Medical Financial Statements

CompuGroup Medical shareholders use historical fundamental indicators, such as Net Income, to determine how well the company is positioned to perform in the future. Although CompuGroup Medical investors may analyze each financial statement separately, they are all interrelated. The changes in CompuGroup Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on CompuGroup Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Income40 M39 M
Net Income Applicable To Common Shares84.4 M71.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CompuGroup Stock Analysis

When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.